Project Description
Riluzole
Mechanism of action:
Inhibits glutamate release and inactivates voltage-dependent Na+ channels.
Therapeutic Indications:
Amyotrophic Lateral Sclerosis, Ataxia (Orphan), Huntington Disease (Orphan)
Chemical Name:
6-(trifluoromethoxy)-1,3-benzothiazol-2-amine.
Details
Molecular Weight:
| 234.2 g/mol |
Molecular Formula:
C8H5F3N2OS
CAS NO:
1744-22-5
Product Form
Powder
API Name
Riluzole